Asia Pacific: The Anti-infective Agents Market in Asia Pacific, including China, Japan, and South Korea, is experiencing rapid growth due to the increasing awareness about infectious diseases, growing healthcare expenditure, and the rising incidence of drug-resistant infections. The expanding pharmaceutical industry and the focus on developing innovative treatment options are expected to drive market growth in this region.
Europe: The Anti-infective Agents Market in Europe, comprising the United Kingdom, Germany, and France, is characterized by the presence of a well-established healthcare system, high healthcare expenditure, and increasing government initiatives for infection control and prevention. The growing geriatric population, rising prevalence of infectious diseases, and the emergence of new infectious agents are contributing to market growth in this region.